Kostaive

Medicinal product

(Invented) name

Kostaive

Active substance (s)

COVID-19 sa-mRNR vakcina. Zapomeranas

Strength

5 µg/dozėje

Pharmaceutical form

milteliai injekcinei dispersijai

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J07BN01, covid-19, RNA-based vaccine

Marketing authorisation holder

Seqirus Netherlands B.V., Nyderlandai

Date of authorisation

2025-02-12

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Vienoje paruoštoje dozėje (0,5 ml) yra	0.5 ml
COVID-19 sa-mRNR vakcina. Zapomeranas	5 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116657	102756	1102756	flakonas	N20 (320 dozių)		Receptinis	EU/1/24/1873/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-02-12	Registruotas